Leveraged Long + Income HIMS ETF
Not enough financial coverage to compute a composite score for HIMY. This is typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available data still render below.
Company
The Defiance Daily Target 2X Long HIMS ETF (the “Fund”) seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of Hims & Hers Health, Inc. (NYSE: HIMS). Because the Fund seeks daily leveraged investment results, it is very different from most other exchange-traded funds and there is no guarantee that the Fund will meet its stated objective.
- CEO
- Scott Snyder
- IPO
- 2025
- HQ
- Milwaukee, WI, US
Price Chart
Valuation
- Market Cap
- $1.07M
- Div Yield
- 102.38%
Performance & Tape
- 52W High
- $28.09
- 52W Low
- $4.63
- 50D MA
- $7.85
- 200D MA
- $14.54
- Beta
- 0.00
- Avg Volume
- 47.57K
Get TickerSpark's AI analysis on HIMY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HIMY Coverage
We haven't published any research on HIMY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HIMY Report →